| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cantor Fitzgerald analyst C.J. Muse reiterates NVIDIA (NASDAQ:NVDA) with a Overweight and maintains $300 price target.
(Editor’s note: The future prices of benchmark tracking ETFs, the earnings, and the headline were updated in the story.) U.S...
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeuti...
authID (Nasdaq: AUID), a leader in biometric identity authentication, today announced it has joined the NVIDIA Connect Program,...
Rosenblatt analyst Kevin Cassidy maintains NVIDIA (NASDAQ:NVDA) with a Buy and raises the price target from $240 to $245.
SuperX AI Technology Limited (NASDAQ:SUPX) ("the Company" or "SuperX") today announced that on November 19, 202...
NVDA: 6% | NVIDIA shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 ...
HUMAIN expands partnership with Nvidia and AWS to accelerate AI infrastructure in Saudi Arabia and U.S. with plans for 600,000 ...
Keybanc analyst John Vinh maintains NVIDIA (NASDAQ:NVDA) with a Overweight and raises the price target from $250 to $275.